BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10951585)

  • 1. The Src/Csk regulatory circuit arose early in metazoan evolution.
    Miller MA; Malik IA; Shenk MA; Steele RE
    Oncogene; 2000 Aug; 19(34):3925-30. PubMed ID: 10951585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and expression of STK, a src-related gene in the simple metazoan Hydra attenuata.
    Bosch TC; Unger TF; Fisher DA; Steele RE
    Mol Cell Biol; 1989 Oct; 9(10):4141-51. PubMed ID: 2479820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a gene encoding a novel protein-tyrosine kinase containing SH2 domains and ankyrin-like repeats.
    Chan TA; Chu CA; Rauen KA; Kroiher M; Tatarewicz SM; Steele RE
    Oncogene; 1994 Apr; 9(4):1253-9. PubMed ID: 8134129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.
    Wang B; Lemay S; Tsai S; Veillette A
    Mol Cell Biol; 2001 Feb; 21(4):1077-88. PubMed ID: 11158295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mechanism of regulation of the non-receptor protein tyrosine kinase Csk: insights from NMR mapping studies and site-directed mutagenesis.
    Shekhtman A; Ghose R; Wang D; Cole PA; Cowburn D
    J Mol Biol; 2001 Nov; 314(1):129-38. PubMed ID: 11724538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
    Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
    Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo suppression of osteoclast function by adenovirus vector-induced csk gene.
    Miyazaki T; Takayanagi H; Isshiki M; Takahashi T; Okada M; Fukui Y; Oda H; Nakamura K; Hirai H; Kurokawa T; Tanaka S
    J Bone Miner Res; 2000 Jan; 15(1):41-51. PubMed ID: 10646113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophosphorylation of Src and Yes blocks their inactivation by Csk phosphorylation.
    Sun G; Sharma AK; Budde RJ
    Oncogene; 1998 Sep; 17(12):1587-95. PubMed ID: 9794236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide and protein phosphorylation by protein tyrosine kinase Csk: insights into specificity and mechanism.
    Sondhi D; Xu W; Songyang Z; Eck MJ; Cole PA
    Biochemistry; 1998 Jan; 37(1):165-72. PubMed ID: 9425036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the communication between the regulatory and catalytic domains of a protein tyrosine kinase, Csk.
    Lin X; Ayrapetov MK; Lee S; Parang K; Sun G
    Biochemistry; 2005 Feb; 44(5):1561-7. PubMed ID: 15683240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct roles of the Src family kinases, SRC-1 and KIN-22, that are negatively regulated by CSK-1 in C. elegans.
    Hirose T; Koga M; Ohshima Y; Okada M
    FEBS Lett; 2003 Jan; 534(1-3):133-8. PubMed ID: 12527374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early emergence of negative regulation of the tyrosine kinase Src by the C-terminal Src kinase.
    Taskinen B; Ferrada E; Fowler DM
    J Biol Chem; 2017 Nov; 292(45):18518-18529. PubMed ID: 28939764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of the csk gene suppresses tumor metastasis in vivo.
    Nakagawa T; Tanaka S; Suzuki H; Takayanagi H; Miyazaki T; Nakamura K; Tsuruo T
    Int J Cancer; 2000 Nov; 88(3):384-91. PubMed ID: 11054667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appearance and disappearance of Syk family protein-tyrosine kinase genes during metazoan evolution.
    Steele RE; Stover NA; Sakaguchi M
    Gene; 1999 Oct; 239(1):91-7. PubMed ID: 10571038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Domain interactions in protein tyrosine kinase Csk.
    Sondhi D; Cole PA
    Biochemistry; 1999 Aug; 38(34):11147-55. PubMed ID: 10460171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SRC tail phosphorylation is limited by structural changes in the regulatory tyrosine kinase Csk.
    Lieser SA; Shaffer J; Adams JA
    J Biol Chem; 2006 Dec; 281(49):38004-12. PubMed ID: 17018524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subdomain switching reveals regions that harbor substrate specificity and regulatory properties of protein tyrosine kinases.
    Wang YH; Huang K; Lin X; Sun G
    Biochemistry; 2007 Sep; 46(35):10162-9. PubMed ID: 17691821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural elements and allosteric mechanisms governing regulation and catalysis of CSK-family kinases and their inhibition of Src-family kinases.
    Ia KK; Mills RD; Hossain MI; Chan KC; Jarasrassamee B; Jorissen RN; Cheng HC
    Growth Factors; 2010 Oct; 28(5):329-50. PubMed ID: 20476842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)--endogenous negative regulators of Src-family protein kinases.
    Chong YP; Mulhern TD; Cheng HC
    Growth Factors; 2005 Sep; 23(3):233-44. PubMed ID: 16243715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Src and Csk nonreceptor tyrosine kinases in the filasterean Ministeria vibrans.
    Schultheiss KP; Craddock BP; Suga H; Miller WT
    Biochemistry; 2014 Mar; 53(8):1320-9. PubMed ID: 24520931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.